Researchers find potential target to prevent CRC spread

09/14/2011 | Genetic Engineering & Biotechnology News

Vanderbilt University researchers said a protein called blood vessel epicardial substance may be a potential drug target for preventing the spread of colorectal cancer. They reported in the Journal of Clinical Investigation that BVES is downgraded in colorectal cancer, which leads to cancer spread, but that reintroducing it can stop cells from beginning the metastasis process.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA